Form C PDX BIOTECH LLC
- Wall St starts fourth quarter on a high note
- Tesla (TSLA) Now 'Unlikely' to Hit Its 50% Delivery Growth Goal for 2022 - Analyst
- Citi Cuts Year-end S&P 500 Price Target to 4000, Introduces 2023 PT of 3900
- Oil jumps $4 as OPEC+ weighs biggest output cut since 2020
- Goldman: We Forecast Further Selling in 2023, Households Could Sell $100 Billion in Equities
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
C 0001941155 XXXXXXXX LIVE false false false PDX BIOTECH LLC Limited Liability Company KY 12-10-2019 404 Clydebank Court Louisville KY 40243 https://orastripdx.com/ N StartEngine Capital, LLC 0001665160 007-00007 up to 9% percent Three percent (3%) of securities of the total amount of investments raised in the offering, along the same terms as investors. Other Non-Voting Units 500 20.00000 N/A 10000.00 Y Other At issuer's discretion, with priority given to StartEngine Owners 1070000.00 11-10-2022 10 6630.00 4081.00 3103.00 45.00 0.00 0.00 0.00 0.00 0.00 0.00 37090.00 31675.00 19199.00 16934.00 0.00 0.00 -16487.00 -768.00 AL AK AZ AR CA CO CT DC DE FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX UT VT VA WA WV WI WY PDX BIOTECH LLC John Beran Manager John Beran Manager 08-12-2022 Reggie Gresham Manager 08-12-2022
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IsoTruss Engineers Critical Tower Solution for Wyoming Bureau of Land Management
- Teijin Automotive Technologies Announces the Retirement of CEO Steve Rooney
- How to Prepare Your Home for an Electric Vehicle
Create E-mail Alert Related CategoriesSEC Filings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!